N Verses Capital, LLC Artivion, Inc. Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
A detailed history of N Verses Capital, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,300 shares of AORT stock, worth $37,791. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,300
Previous 1,100
18.18%
Holding current value
$37,791
Previous $28.2 Million
22.65%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AORT
# of Institutions
164Shares Held
35.1MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$193 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$81.7 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81.2 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$80.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$68.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.17B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...